The Global Cardiovascular Surgery Devices Market is Forecast to Reach $1.6 Billion in 2017

Tuesday 10 April 2012, Amsterdam

The report provides information on the market landscape and competitive landscape, and market trend information for four cardiovascular surgery devices market categories: perfusion disposables, beating heart surgery systems, cardiopulmonary bypass (CPB) equipment and cardiac ablation devices. The report provides comprehensive information on the key trends affecting these categories and key analytical content of market dynamics. The report also reviews the competitive landscape, major mergers and acquisitions in the last six years and a detailed analysis of the pipeline products in each category.


The Global Cardiovascular Surgery Devices Market is Forecast to Reach $1.6 Billion in 2017

See figure: Cardiovascular Surgery Devices Market, Global, Overall Revenues ($bn), 2010-2017

The global cardiovascular surgery devices market is forecast to reach $1.6 billion by 2017, with a compound annual growth rate (CAGR) of -1.3% from 2010-2017. The cardiovascular surgery devices market is expected to decline in this period due to the increasing adoption of alternative treatment procedures, such as percutaneous coronary intervention (PCI) and other minimally invasive interventions, and the shortage of cardiac surgeons in the US. In addition to this, a falling average selling price (ASP) and cost containment pressures in developed economies will also negatively affect the cardiovascular surgery devices market.


Perfusion Disposables Market is the Largest Category in the Global Cardiovascular Surgery Devices Market

The perfusion disposables market emerged as the largest category in the global cardiovascular surgery devices market in 2010. The perfusion disposables market accounted for 79% of the total cardiovascular surgery devices market. The global perfusion disposables market was valued at $1.4 billion in 2010 and is forecast to decline at a CAGR of 1.5% from 2010-2017, to reach $1.3 billion. The beating heart surgery systems market accounted for 12% of the total cardiovascular surgery devices market and was worth $0.2 billion in 2010.


The US is the Biggest Market in the Cardiovascular Surgery Devices Market

The US is the biggest market for cardiovascular surgery devices, contributing to 38% and accounting for $688m of the global market in 2010. The cardiovascular surgery devices market in the US is forecast to decline at a CAGR of -1.6%, to reach a market value of $616.1m in 2017.

Factors such as the aging and increasing patient population and minimally invasive procedures are maintaining demand for devices. However, the increasing adoption of alternative treatment procedures and the shortage of cardiovascular surgeons in the US will negatively affect the growth of the cardiovascular surgery devices market.


Medtronic Led the Global Cardiovascular Surgery Devices Market in 2010

In 2010, Medtronic was the largest player in the global cardiovascular surgery devices market, with a market share of 24%. This was followed by Sorin with 19%, MAQUET with 15% and Terumo Corporation with 5%. The global cardiovascular surgery devices market is dominated by established companies which collectively account for 63% of the total market. Medtronic’s market dominance can be attributed to its global reach, brand presence and technologically advanced products. Medtronic dominates the North American market, which is the largest global market for cardiovascular surgery devices.